This expansion is a key milestone in our long-term plan to strengthen support for pharmaceutical and biotechnology partners who rely on Labcorp for complex CMC, bioanalytical, and regulatory testing services. Labcorp is expanding its global BioPharmaceutical Chemistry, Manufacturing and Control (CMC) footprint and is opening a new, purpose-built CMC facility in Mechelen, Belgium. This facility will introduce a new CMC analytical testing solution for commercial drug products in the European Union (EU). With a strong portfolio of clients and over 25 years of expertise this team provides advanced characterization, method development, stability and routine QC release for biologics, vaccines, ATMP's, and a breadth of other complex biomolecules. With this new laboratory in Belgium, we aim to offer a more comprehensive solution and accelerate the availability of new products for patients.
plus